GPT and metabolic dysfunction-associated steatotic liver disease: One of the main limitations fueling the controversy between the association of NAFLD and BMD is that most studies till date have based the diagnosis of NAFLD on ultrasonographic evidence of hepatic steatosis, with an elevated alanine aminotransferase (ALT) serving as a surrogate marker for the presence of NASH.